Pyrrolidine → 3-[1-(6-Ethoxy-2-morpholino-7-pyrrolidinylcarbonylmethoxy-4-quinazolinyl)-4-piperidinyl]-1,2,3,4-tetrahydro-1,6-dimethyl-2,4-dioxoquinazoline

HRID 617167Notes

Reaction equation

HRID 617167 reaction equation
[C:1]([CH2:4][O:5][C:6]1[CH:15]=[C:14]2[C:9]([C:10]([N:22]3[CH2:27][CH2:26][CH:25]([N:28]4[C:37](=[O:38])[C:36]5[C:31](=[CH:32][CH:33]=[C:34]([CH3:39])[CH:35]=5)[N:30]([CH3:40])[C:29]4=[O:41])[CH2:24][CH2:23]3)=[N:11][C:12]([N:16]3[CH2:21][CH2:20][O:19][CH2:18][CH2:17]3)=[N:13]2)=[CH:8][C:7]=1[O:42][CH2:43][CH3:44])(O)=[O:2].[NH:45]1[CH2:49][CH2:48][CH2:47][CH2:46]1>>[CH2:43]([O:42][C:7]1[CH:8]=[C:9]2[C:14](=[CH:15][C:6]=1[O:5][CH2:4][C:1]([N:45]1[CH2:49][CH2:48][CH2:47][CH2:46]1)=[O:2])[N:13]=[C:12]([N:16]1[CH2:21][CH2:20][O:19][CH2:18][CH2:17]1)[N:11]=[C:10]2[N:22]1[CH2:27][CH2:26][CH:25]([N:28]2[C:37](=[O:38])[C:36]3[C:31](=[CH:32][CH:33]=[C:34]([CH3:39])[CH:35]=3)[N:30]([CH3:40])[C:29]2=[O:41])[CH2:24][CH2:23]1)[CH3:44]

Participants

3

Procedure

The same procedure as in Example 57 was repeated, using 300 mg (0.50 mmol) of Compound 56 obtained in Example 56, except that pyrrolidine was used in place of isopropylamine, to give 48 mg (yield: 15%) of Compound 58 as white crystals.

Sources & evidence

ORD record
ord-1ed6f585f205431d8a1af9728fe374ef
Source dataset
uspto-grants-1999_09
Patent number
US05948784

Reaction notes

Loading…